German Version German Version
  Accessibility    Contact MedUni Vienna    Intranet    MedUni Vienna - Shop    University Library    Vienna General Hospital (AKH Wien)  
 
 
 
 
General Information / Team / Judit Simon
 

Judit Simon, MD (Hons) BA BSc MSc DPhil FFPH

Professor of Health Economics

Head of Department

Deputy Head of Center

Coordinator Doctoral Programme Public Health 

Phone (PA): +43 1 40160 - 34842

E-Mail: judit.simon@meduniwien.ac.at

Location: Kinderspitalgasse 15, 1st floor, room 138

Judit Simon is Professor of Health Economics and Head of the Department of Health Economics. She also holds the functions of Deputy Head of the Centre for Public Health and Coordinator of the Doctoral Programme Public Health at the Medical University of Vienna.

Her other current affiliations include:

- Head of Health Economics, Ludwig Boltzmann Institute Applied Diagnostics;
- Visiting Professor of Cognitive Health Economics at the Department of Psychiatry, University of Oxford; and
- Research Associate of the Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford.

She previously held appointments at the UK National Collaborating Centre for Mental Health, University College London (UCL), the London School of Economics and Political Science (LSE); the Institute of Psychiatry, King’s College London; the Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford; and the Oxford Health NHS Foundation Trust.

Professor Simon holds a DPhil in Public Health from the University of Oxford; an MSc in Health Economics from the University of York; and a Doctor of Medicine (MD), a BSc in Economics and a BA in Medical Translation from the University of Szeged. She is Fellow through Distinction of the UK Faculty of Public Health (FFPH).

Her work focuses on applied and methodological research in health economics and public health. Main expertise include economic evaluation in health and medicine, planning and conducting clinical studies/RCTs, clinical guideline development, health services research, health systems research, outcomes/effectiveness research, cost and economic burden studies, and evidence synthesis. Specific research areas lie in the fields of mental health, public health, nutrition, cancer and chronic diseases, personalised medicine and translational research, capabilities and costing methods.

 

Publications

2021

 

2020

 

2019


2018


2017


2016


2015


2014

  • Vergunst F, Jenkinson C, Burns T, Simon, J (2014) Application of Sen's Capability Approach to Outcome Measurement in Mental Health Research: Psychometric Validation of a Novel Multi-dimensional Instrument (OxCAP-MH). Human Welfare 3, 1, 1-4.
  • Abdul Pari Anees A, Simon J, Wolstenholme J, Geddes JR, Goodwin GM (2014) Economic evaluations in bipolar disorder: a systematic review and critical appraisal. Bipolar Disorders, Volume 16, Issue 6, pages 557–582. doi: 10.1111/bdi.12213.


2013 and before

  • Simon J, Anand P, Gray A, Rugkåsa J, Yeeles K, Burns T (2013) Operationalising the capability approach for outcome measurement in mental health research Social Science & Medicine, 98:187–196. doi: 10.1016/ j.socscimed.2013.09.019
  • Miklowitz DJ, Price J, Holmes EA, Rendell J, Bell S, Budge K, Christensen J, Wallace J, Simon J, Armstrong NM, McPeake L, Goodwin GM, Geddes JR (2012) Facilitated Integrated Mood Management for adults with bipolar disorder. Bipolar Disorder Mar 2012; 14(2): 185–197. doi:  10.1111/j.1399-5618.2012.00998.x
  • Simon J, Budge KV, Goodwin G, Geddes J (2011) Health economic preparatory work for OXTEXT: The development and evaluation of cost-effective systems of collaborative disease management for people with bipolar disorder. Journal of Mental Health Policy and Economics, 14(Suppl.1): S32.
  • Farmer A J, Wade A N, French D P, Simon J, Yudkin P, Gray A, Craven A, Goyder L, Holman R R, Mant D, Kinmonth A-L, Neil H AW (2009) Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial. Health Technol Assess. 2009 Feb;13(15):iii-iv, ix-xi, 1-50. doi: 10.3310/hta13150.
  • Simon J, Petrou S, Gray A. (2009) The valuation of prenatal life in economic evaluations of perinatal interventions. Health Economics, 18(4): 487-494.
  • Simon J, et al. (2009) A vércukorszint otthoni monitorozásának költséghatékonysága 2-es típusú cukorbetegségben. Lege Artis Medicinae, 19(1): 45.
  • Simon J, Gray A, Wade A, Neil A, Farmer A, on behalf of the Diabetes Glycaemic Education and Monitoring Trial Group (2008) Cost-effectiveness of self-monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. British Medical Journal, 336: 1177-1180. doi: 10.1136/bmj.39526.674873.BE
  • Zechmeister I, Kilian R, McDaid D, the MHEEN group (2008) Is it worth investing in mental health promotion and prevention of mental illness? A systematic review of the evidence from economic evaluations. BMC Public Health, 8: 20.
  • Knapp M, McDaid D, Evers S, Salvador-Carulla L, Halstein V, the MHEEN group (2008) Cost-effectiveness and Mental Health, MHEEN II Policy Briefing 2, Personal Social Services Research Unit, London.
  • McDaid D, Knapp M, Medeiros H, the MHEEN group (2008) Employment and Mental Health: Assessing the Economic Impact and the Case for Intervention, MHEEN II Policy Briefing 5. Personal Social Services Research Unit, London.
  • McDaid D, Zechmeister I, Kilian R, Medeiros H, Knapp M, Kennelly B, the MHEEN group (2008) Making the Economic Case for the Promotion of Mental Well-being and the Prevention of Mental Health Problems, MHEEN II Policy Briefing 3. Personal Social Services Research Unit, London.
  • Medeiros H, McDaid D, Knapp M, the MHEEN group (2008) Shifting Care from Hospital to the Community in Europe: Economic Challenges and Opportunities, MHEEN II Policy Briefing 4. Personal Social Services Research Unit, London.
  • Knapp M, McDaid D, Medeiros H, Becker T, Johnson S, Kilian R, Salvador-Carulla L, Simon J, Tatar M, on behalf of the MHEEN group (2008) Economics, Mental Health and Policy: An Overview, MHEEN II Policy Briefing 1. Personal Social Services Research Unit, London.
  • MAGPIE Trial Follow Up Study Collaborative Group (2007) The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months. BJOG-INT J OBSTET GY, 114(3): 289-299.
  • MAGPIE Trial Follow Up Study Collaborative Group (2007) The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years. BJOG-INT J OBSTET GY, 114(3): 300-309.
  • McDaid D, Knapp M, Medeiros H, the MHEEN group (2007) Mental health and economics in Europe. Findings from the MHEEN group. Eurohealth, 13(3): 1-6.
  • Simon J, Gray A, Wade A, et al. (2007) Cost-effectiveness of self-monitoring of blood glucose for the management of patients with non-insulin treated type 2 diabetes: economic evaluation of the DiGEM trial. Diabetologia, 50(Suppl.1): S431.
  • Simon J, Pilling S, Goldberg D, Burbeck R (2006) Treating moderate and severe depression with antidepressant therapy or combination of antidepressants and psychological therapy: a decision analysis supporting a clinical guideline. British Journal of Psychiatry, 189: 494-501.
  • Clarke PM, Simon J, Cull CA, Holman RR (2006) Assessing the impact of visual acuity on quality of life in people with type 2 diabetes using the SF-36. Diabetes Care, 29: 1506-1511.
  • Simon J, Gray A, Duley L, on behalf of the MAGPIE Trial Collaborative Group (2006) Cost effectiveness of prophylactic magnesium sulphate in 9996 women with pre-eclampsia from 33 countries: Economic evaluation of the Magpie Trial. BJOG, 113: 144-151.
  • Gervain J, Simon J, Czibula A, et al. (2006) The correlation of genom mutations in HCV-1b with IFN-sensitivity in Hungarian patients. Journal of Gastroenterology and Hepatology, 21(Suppl.2): A139-A139.
  • Simon J, Patel A, Sleed M (2005) The costs of alcoholism. Journal of Mental Health, 14(4): 321-330.
  • Simon J, Schmidt U, Pilling S, on behalf of the Eating Disorders Guideline Development Group (2005) The health service use and cost of eating disorders. Psychological Medicine, 35(11): 1543-1551.
  • National Collaborating Centre for Mental Health (2004) Depression: management of depression in primary and secondary care. Clinical Guideline 23. NICE: London.
  • Knapp M, Mangalore R, Simon J (2004) The global costs of schizophrenia. Schizophrenia Bulletin, 30: 279-293.
  • Petrou S, Boulvain M, Simon J, Maricot P, Borst F, Irion O (2004) Home-based care after a shortened hospital stay versus hospital-based care postpartum: An economic evaluation. BJOG, 111: 800-806.
  • National Collaborating Centre for Mental Health (2004) Eating disorders: Core interventions in the treatment and management of anorexia nervosa, bulimia nervosa and related eating disorders. Clinical Guideline 9. NICE: London.
  • National Collaborating Centre for Mental Health (2004) Depression: management of depression in primary and secondary care. National Clinical Practice Guideline CG23. Gaskell Press: London.
  • Richardson G, Wonderling D, Simon J, Wailoo A, Douglas HR, Culyer AJ, Tsuchiya A, Roberts J, Drummond MF, on behalf of the Health Economists in Guidelines group (2004) Incorporating health economics in guidelines and assessing resource impact. In: NICE. Guideline development methods: Information for National Collaborating Centres and Guideline Developers. NICE: London.  
  • National Collaborating Centre for Mental Health (2004) Eating disorders: Core interventions in the treatment and management of anorexia nervosa, bulimia nervosa and related eating disorders. National Clinical Practice Guideline CG9. Gaskell Press: London.
  • Gervain J, Simon G, Simon J, the Hungarian Viral Hepatitis Group (2003) Genotype distribution of hepatitis C virus in the Hungarian population with chronic viral hepatitis C. European Journal of Gastroenterology and Hepatology, 15(4): 449-450.
  • Gervain J, Czibula A, Simon J, Kalmar T (2003) Structural analysis of the PKR-binding region of HCV 1b samples from patients with chronic hepatitis C and the correlation with IFN-sensitivity. Orvosi Hetilap, 144: 1179-1184.
  • National Collaborating Centre for Mental Health (2003) Schizophrenia: Core interventions in the treatment and management of schizophrenia in primary and secondary care. National Clinical Practice Guideline CG1. Gaskell Press: London.
  • Simon J (2003) Cost-conscious clinical guidelines: the schizophrenia guideline example. Mental Health Research Review, 9:42-43.
  • Simon J, Whittington C, on behalf of the Eating Disorders Guideline Development Group (2003) Cost-effectiveness of antidepressant therapy, cognitive behaviour therapy and their combination for people with bulimia nervosa in the UK. Value in Health, 6(6): A619-A620.  
  • National Collaborating Centre for Mental Health (2002) Schizophrenia: Core interventions in the treatment and management of schizophrenia in primary and secondary care. Clinical guideline 1. NICE: London.
  • Knapp M, Simon J (2002) Cost implications of schizophrenia in the community. Psychiatry, 1(10): 69-72.
  • Knapp M, Simon J, Almond S, Percudani M (2002) Costs of Schizophrenia: A Review. In: Maj M. (ed.) Schizophrenia (2nd ed). John Wiley & Sons Ltd.: Chichester.
  • Gervain J, Czibula A, Kalmar T, Simon J, Papp I, Szabo K. (2002) Mutations of the NS5A domain of HCV subtype 1b and response to interferon therapy in Hungarian patients. Zeitschrift fuer Gastroenterologie, 40: A334.
  • Balati B, Jost N, Simon J, Varro A, Papp JGy (2000) Analysis of the electrophysiological effects of ambasilide, a new antiarrhythmic agent in canine isolated ventricular muscle and Purkinje fibres. General Pharmacology, 34(2): 85-93.
  • Baláti B, Iost N, Simon J, Varró A, Papp JGy (2000) Az ambasilid, egy antiaritmiás szer elektrofiziológiai hatásainak vizsgálata izolált kutyaszív preparátumokon. Cardiologia Hungarica, Suppl 3: S46.
  • Baláti B, Takács J, Iost N, Virág L, Simon J, Varró A, Papp JGy (1999) The role of the slow component of the delayed rectifier potassium current in dog ventricular muscle and Purkinje fibre repolarization. Fundamental and Clinical Pharmacology, 13(Suppl 1): S226.
  • Baláti B, Takács J, Iost N, Virág L, Simon J, Varró A, Papp JG. (1999) A "delayed rectifier" káliumáram lassú komponensének szerepe a kutyaszív kamrai munkaizom és Purkinje rostjainak repolarizációjában. Cardiologia Hungarica, Suppl 2: S19.
  • Baláti B, Simon J, Varró A, Papp JGy (1998) Cellular electrophysiological effects of chromanol 293B in canine ventricular muscle. Journal of Molecular and Cellular Cardiology, 30: A133.
 
Drucken
 

Quick Links

 
 

Featured

 
 
 
 
 
© MedUni Wien | Publishing information | Terms of use | Contact